Salarius Pharmaceuticals Inc. (NASDAQ: SLRX)
$1.54
-0.2400 ( -13.50% ) 1.2M
Salarius Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing effective treatments for cancers with high, unmet medical needs. The company has focused on two classes of drugs that address gene dysregulation: targeted protein inhibitors and targeted protein degradation. Its Pipeline includes seclidemstat (SP-2577), a small molecular inhibitor, and SP-3164, a small molecular protein degrader.
Market Data
Open
$1.54
Previous close
$1.78
Volume
1.2M
Market cap
$0.93M
Day range
$1.41 - $2.13
52 week range
$1.41 - $9.92
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 14 | Aug 10, 2023 |
10-q | Quarterly Reports | 43 | Aug 10, 2023 |
8-k | 8K-related | 14 | Jul 12, 2023 |